$0.00
Cancer Times focuses on the negative opinion most activist groups have about National Breast Cancer Awareness Month. Critics charge the month is a PR gimmick and question AstraZeneca's sponsorship of the month. They say AstraZeneca advises early detection and its drug tamoxifen for "high-risk" women.
Looks like you haven't made a choice yet.